Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan

OBJECTIVE: Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally. Although the relationship between anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies and COVID-19 severity has been reported, information is lacking regarding the se...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Takayuki, Hagihara, Masao, Mitamura, Keiko, Nakashima, Shiori, Ohara, Shin, Uchida, Tomoyuki, Inoue, Morihiro, Okuda, Moe, Yasuhara, Atsuhiro, Murakami, Jurika, Duong, Calvin, Iwatsuki-Horimoto, Kiyoko, Yamayoshi, Seiya, Kawaoka, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259303/
https://www.ncbi.nlm.nih.gov/pubmed/35342138
http://dx.doi.org/10.2169/internalmedicine.9209-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259303/
https://www.ncbi.nlm.nih.gov/pubmed/35342138
http://dx.doi.org/10.2169/internalmedicine.9209-21

Ejemplares similares